[1] Befani C,Mylonis I,Gkotinakou IM,et al.Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells[J].Int J Biochem Cell Biol,2013,45(11):2359-2368.[2] 尹中普,孙晓.HIF-1α和GLUT-1在鼻咽癌组织中的表达及其临床意义[J].中国肿瘤生物治疗杂志,2015,22(4):495-499.[3] 聂弘,高从荣,赵敏,等.HIF-1α、Survivin在非小细胞肺癌中的表达[J].安徽医科大学学报,2015,50(11):1674-1676.[4] Giatromanolaki A,Sivridis E,Fiska A,et al.Hypoxia-inducible factor-2 alpha(HIF-2 alpha)induces angiogenesis in breast carcinomas[J].Appl Immunohistochem Mol Morphol,2006,14(1):78-82.[5] 李军,王晓敏,宋张骏,等.非小细胞肺癌中Ki-67和BCL-2表达的临床意义及预后价值[J].临床与实验病理学杂志,2012,28(8):921-924.[6] Koh MY,Lemos R Jr,Liu X,et al. The hypoxia associated factor switches cells from HIF-1α-to HIF-2α dependent signaling promoting stem cell characteristics,aggressive tumor growth and invasion[J].Cancer Res, 2011,71(11):4015-4027.[7] 孙菊杰,魏玲,张德贤,等.非小细胞肺癌中Snail、HIF-1α和E-cadherin表达的临床意义及相关性[J].肿瘤防治研究,2015,42(1):37-42.[8] Keith B,Johnson RS,Simon MC.HIF1α and HIF2α:sibling rivalry in hypoxic tumour growth and progression[J].Nat Rev Cancer,2012,12(1):9-22.[9] Zhao J,Du F,Shen G,et al.The role of hypoxia-inducible factor-2 in digestive system cancers[J].Cell Death Dis,2015,6:e1600.[10] Martin SK,Diamond P,Williams SA,et al.Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells[J].Haematologica,2010,95(5):776-784.[11] 金静思,贺巾钊.非小细胞肺癌分子靶向治疗药物的现状及进展[J].中国肿瘤临床,2015,42(17):881-885.[12] Dowsett M,Nielsent TO,A'Hern R,et al.Assessment of Ki67 in breast cancer:recommendations from the international Ki67 in breast cancer working group[J].J Nat Cancer Inst,2011,103(22):1656-1664.[13] 董亮,钱震,施蓉蓉,等.结直肠腺癌组织中p53、HER-2和Ki-67的表达及其临床病理意义[J].诊断病理学杂志,2015,22(1):19-22.[14] 邬万新,张怡,郭志琴,等.Ki-67检测结果与乳腺癌临床病理指标的相关性分析[J].中华病理学杂志,2015,44(9):657-658.[15] Semenza GL.Molecular mechanisms mediating metastasis of hypoxic breast cancer cells[J].Trends Mol Med,2012,18(9):534-543. |